SNG — Synairgen Share News
0.000.00%
- £9.35m
- -£2.66m
- 10
- 35
- 31
- 14
REG - Synairgen plc - SNG001 progresses to Phase 3 of ACTIV-2 trial
AnnouncementRCS - Synairgen plc - Synairgen appoints Gareth Walters, Ph.D. as CRO
AnnouncementREG - Synairgen plc - Holding(s) in Company
AnnouncementREG - Synairgen plc - Non-Executive Director Appointment
AnnouncementREG - Synairgen plc - Interim results
AnnouncementREG - Synairgen plc - Synairgen Notice of Interim Results
AnnouncementREG - Synairgen plc - Holding(s) in Company
AnnouncementREG - Synairgen plc - Exercise of Options and Total Voting Rights
AnnouncementREG - Synairgen plc - Holding(s) in Company
AnnouncementREG - Synairgen plc - Holding(s) in Company
AnnouncementREG - Synairgen plc - Result of AGM
AnnouncementREG - Synairgen plc - Grant of Options
AnnouncementREG - Synairgen plc - Notice of AGM
AnnouncementRCS - Synairgen plc - Results of in vitro studies
AnnouncementREG - Synairgen plc - Full Year Results
AnnouncementREG - Synairgen plc - Home Cohort data of SG016 Phase II trial
AnnouncementREG - Synairgen plc - Holding(s) in Company
AnnouncementREG - Synairgen plc - Holding(s) in Company
AnnouncementREG - Synairgen plc - Holding(s) in Company
Announcement